Rishmak Production and Export Company (RISHMAK) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- RISHMAK
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 674,500 | 1,194,900 | 1,269,116 | 1,373,127 | 469,228 | 75,612 |
| Cost of operating revenue | -280,100 | -557,499 | -444,584 | -446,699 | -229,434 | -26,144 |
| Gross profit (loss) | 394,400 | 637,401 | 824,532 | 926,428 | 239,794 | 49,468 |
| Selling, general and administrative expenses | -224,354 | -134,567 | -73,575 | -56,131 | -31,957 | -28,461 |
| Other income | 1,894,573 | 726,716 | 447,189 | 628,923 | 25,000 | 27,581 |
| Other expenses | -888,780 | -259,792 | -340,640 | -138,502 | -72,001 | -46,659 |
| Operating profit (loss) | 1,175,839 | 969,758 | 857,506 | 1,360,718 | 160,836 | 1,929 |
| Other non-operating income and expenses | 66,157 | 43,257 | 51,597 | 29,590 | 1,410 | 3,895 |
| Profit (loss) from continuing operations before tax | 1,241,996 | 1,013,015 | 909,103 | 1,389,251 | 150,030 | 436 |
| Net profit (loss) from continuing operations | 1,181,459 | 1,013,015 | 909,103 | 1,389,251 | 150,030 | -114 |
| Net profit (loss) | 1,181,459 | 1,013,015 | 909,103 | 1,389,251 | 150,030 | -114 |
| Basic earnings (loss) per share | 1,181 rials | 1,013 rials | 909 rials | 1,389 rials | 500 rials | -1 rials |
| Net earnings (loss) per share, rials | 1,182 rials | 1,014 rials | 910 rials | 1,390 rials | 501 rials | 0 rials |
| Capital | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 300,000 | 300,000 |
Reporting periods
57 periods are on file for this report, from the period ending 1394/09/30 to the period ending 1405/06/31.